Beni VC
VC Fund
Miami, United States
Beni VC is a VC fund in Miami focused on Biotechnology and Health Care. We provide early-growth stage capital to transformational venture-backed technology businesses.We believe in partnering with the very best entrepreneurs and top-tier early-stage investors to help build enduring technology companies. We operate under the premise that the only way to build a world class business is to always put the company first. Webelieve this ethos optimizes outcomes for our companies and Limited Partners alike.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Beni VC invests in
Stages Beni VC invests in
Countries Beni VC invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ciro Campagnoli
|
|||
Ofir Tahor
|
|||
Investment Focus
Industry
- Biotechnology 7 (18%)
- Health Care 5 (13%)
- Big Data 4 (11%)
- Software 4 (11%)
- Medical Device 3 (8%)
Stage
- Seed 18 (47%)
- Series A 9 (24%)
- Funding Round 2 (5%)
- Series B 1 (3%)
- Venture - Series Unknown 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ciro Campagnoli
Founder
|
Founder | Total investments: 0 | Find email | |
|
Ofir Tahor
Venture Partner
|
Venture Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bucha Bio
|
Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more.Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product. | $1.1M / Seed / Sep 27, 2022 | |
Personal AI
|
Personal AI builds memory infrastructure for AI systems. The company's identity-based memory architecture powers specialized Small Language Models (SLMs) that deliver superior precision, latency, and cost efficiency compared to centralized cloud LLMs. By replacing context-window-based personalization with persistent, multi-layered memory,Personal AI enables real-time, personalized AI experiences at scale. The platform is purpose-built for distributed deployment on telecommunications infrastructure, supporting privacy-first, on-network AI integrated with voice, text, and data services. | $2.5M / Seed / Sep 01, 2022 | |
Freedom Biosciences
|
Freedom Biosciences is a biotechnology platform developing next-generation psychedelic therapeutics. | $10.5M / Seed / Aug 23, 2022 | |
Posh
|
POSH provides integrated battery energy storage solutions for commercial and industrial customers. | $3.8M / Seed / Jun 22, 2022 | |
SCiFi Foods
|
SCiFi Foods is a food technology company creating transformational products by combining cultivated meat with plant-based ingredients to make burgers shockingly close to the taste of conventional beef. Already, it has successfully grown beef cells in suspension, which at scale will reduce its cost of production by 1000x—a massive milestone. It wasco-founded by CEO Joshua March, a serial entrepreneur with two prior exits, and CTO Kasia Gora, PhD., who has led R&D teams in bioengineering for more than a decade, most recently at Zymergen. To date, it has raised $29M from leading investors, including Andreessen Horowitz, Valor Siren Ventures, BoxGroup, Entree Capital, and Prelude Ventures, amongst others. | $22M / Series A / Jun 08, 2022 | |
Soar
|
Soar is a real-time streaming platform for volumetric video | Seed / Jan 01, 2022 | |
BioSapien
|
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life. | $1.8M / Seed / Nov 11, 2021 | |
|
Bucha Bio
|
Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more.Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product. | $550K / Seed / Oct 18, 2021 | |
TRIPP
|
TRIPP: Empowering You To Change The Way You FeelNamed the Best VR Meditation App of 2020 by Men’s Health and VR Fitness Insider, The Washington Post calls TRIPP “Meditation-meets-a-video-game-meets-a-Happy-Pill!”TRIPP is the award-winning XR platform designed to address mental and emotional well-being. Proven to drive deep engagement, TRIPPcreates advanced digital products that are based on scientific research and delivered through virtual reality, augmented reality, and mobile devices. TRIPP's platform is currently delivering wellness solutions into consumer households, Fortune 1000 companies and hospitals/clinics worldwide. | $11M / Series A / Jun 25, 2021 | |
Natilus
|
Natilus is a large scale drone manufacturing company. The company specializes in the manufacturing of Boeing 747 sized drones which provides inter-continental cargo delivery services and helps in reducing air freight costs. Natilus was founded by LZ Zhang, Anatoly Starikov and Aleksey Matyushev in 2016.First flight of their 2200 lbs / 30 ftdrone is scheduled for Summer 2018. At the end of 2018, Natilus completed a flight test of their 2200 lbs prototype.The first production vehicle scheduled for 2020 customer delivery underwent wind tunnel testing in April, 2019. Natilus currently holds an aircraft order book rumored to be in excess of $1B+. | Jun 01, 2021 | |
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Beni VC invest in?
Beni VC invests primarily in Biotechnology, Health Care and Big Data startups, most often at Seed and Series A stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Beni VC?
Public channels for Beni VC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Beni VC?
The team at Beni VC includes Ciro Campagnoli (Founder) and Ofir Tahor (Venture Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
